Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Cocaine

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 80353 refers to a laboratory test specifically designed to measure the presence of cocaine in various biological specimens, including meconium stool, urine, serum, or plasma. Cocaine is classified as a highly addictive substance that acts as a central nervous system stimulant and anesthetic, originating from the leaves of the coca plant. This substance functions as a triple reuptake inhibitor (TRI), meaning it influences the brain's neurotransmitter systems by affecting serotonin, norepinephrine, and dopamine receptors. Cocaine can be administered through various routes, including inhalation, injection, or topical absorption. For the purpose of this test, a blood sample is typically obtained through a procedure known as venipuncture, which is separately reportable. Urine samples can be collected either through random voiding or catheterization, while meconium stool is gathered from a diaper. The analysis of serum, plasma, meconium stool, and positive urine screens is conducted using advanced techniques such as quantitative gas chromatography-mass spectrometry and quantitative liquid chromatography-tandem mass spectrometry, ensuring accurate measurement of cocaine levels in the tested specimens.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The laboratory test coded as CPT® 80353 is indicated for the detection and measurement of cocaine in various biological specimens. The following conditions or situations may warrant the performance of this test:

  • Substance Abuse Evaluation This test is often utilized in the assessment of individuals suspected of cocaine use or abuse, providing critical information for treatment and intervention.
  • Monitoring Treatment Patients undergoing treatment for cocaine addiction may be tested to monitor compliance and the effectiveness of therapeutic interventions.
  • Forensic Analysis In legal or forensic contexts, this test may be performed to establish the presence of cocaine in individuals involved in criminal investigations or legal proceedings.
  • Newborn Screening The test may be indicated for newborns, particularly when there is a concern regarding maternal drug use during pregnancy, as cocaine can be detected in meconium stool.

2. Procedure

The procedure for conducting the cocaine test coded as CPT® 80353 involves several key steps to ensure accurate collection and analysis of the specimens. Each step is critical to the integrity of the test results.

  • Specimen Collection The first step involves the collection of the appropriate biological specimens. For serum or plasma testing, a blood sample is obtained through venipuncture, which is a standard procedure where a needle is inserted into a vein to draw blood. Urine samples can be collected either by random voiding, where the patient provides a sample at their convenience, or through catheterization, which involves inserting a catheter into the bladder to obtain urine directly. For meconium stool, the sample is collected from a diaper, which is particularly relevant for newborns.
  • Sample Preparation Once the specimens are collected, they must be properly prepared for analysis. This may involve centrifugation of blood samples to separate serum or plasma from cellular components, as well as appropriate handling and storage of urine and meconium samples to preserve their integrity until testing.
  • Analytical Testing The prepared specimens are then subjected to quantitative analysis using sophisticated laboratory techniques. Quantitative gas chromatography-mass spectrometry and quantitative liquid chromatography-tandem mass spectrometry are employed to accurately measure the concentration of cocaine in the samples. These methods are highly sensitive and specific, allowing for precise detection of cocaine levels.

3. Post-Procedure

After the completion of the cocaine testing procedure, the laboratory will analyze the collected specimens and generate a report detailing the findings. It is essential for healthcare providers to review the results in conjunction with clinical assessments and patient history. Depending on the outcomes, further actions may be warranted, such as additional testing, referrals for substance abuse treatment, or legal reporting in forensic cases. Patients may also be advised on the implications of the test results, particularly in the context of treatment for substance use disorders or legal matters. Proper documentation and communication of the results are crucial for ensuring appropriate follow-up care and interventions.

Short Descr DRUG SCREENING COCAINE
Medium Descr DRUG SCREENING COCAINE
Long Descr Cocaine
Status Code Not Valid for Medicare Purposes
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x)
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T2D - Other tests - other
MUE 1
Date
Action
Notes
2015-01-01 Added Added
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"